Holen Sie sich die Stockscreener-App
0.4163
1.28%
0.0053
Schlusskurs vom Vortag:
$0.411
Offen:
$0.411
24-Stunden-Volumen:
187.88K
Relative Volume:
0.07
Marktkapitalisierung:
$17.06M
Einnahmen:
$653.40K
Nettoeinkommen (Verlust:
$-20.19M
KGV:
-0.2301
EPS:
-1.8091
Netto-Cashflow:
$-11.11M
1W Leistung:
+4.06%
1M Leistung:
+5.86%
6M Leistung:
-35.30%
1J Leistung:
-53.74%
1-Tages-Spanne:
$0.4021
$0.4366
1-Wochen-Bereich:
$0.388
$0.4451
52-Wochen-Spanne:
$0.2382
$2.60
Scienture Holdings Inc Stock (SCNX) Company Profile
Firmenname
Scienture Holdings Inc
Sektor
Branche
Telefon
(800) 261 0281
Adresse
20 AUSTIN BLVD., COMMACK
Compare SCNX vs HITI, PETS, POM, WGRX
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SCNX
Scienture Holdings Inc
|
0.42 | 16.62M | 653.40K | -20.19M | -11.11M | -1.8091 |
HITI
High Tide Inc
|
2.415 | 211.83M | 452.61M | -35.30M | 13.25M | -0.3863 |
PETS
Petmed Express Inc
|
2.22 | 48.37M | 182.67M | -64.87M | -22.92M | -3.1193 |
POM
Pomdoctor Ltd Adr
|
0.1101 | 15.27M | 0 | 0 | 0 | 0.00 |
WGRX
Wellgistics Health Inc
|
0.0879 | 12.29M | 23.34M | -101.27M | -11.74M | -1.2919 |
Scienture Holdings Inc Aktie (SCNX) Neueste Nachrichten
Number of shareholders of Scienture Holdings, Inc. – NASDAQ:SCNX - TradingView
TradingKey - TradingKey
Scienture Holdings Inc (FRA:4E4) Stock Price, Trades & News - GuruFocus
Scienture Holdings Inc expected to post a loss of 22 cents a shareEarnings Preview - TradingView
Scienture (SCNX) Secures Patent for Innovative Losartan Suspensi - GuruFocus
Scienture secures $11M debt financing for product launches By Investing.com - Investing.com South Africa
Scienture secures $11M debt financing for product launches - Investing.com UK
Scienture secures $11.0 million in non-dilutive debt financing to accelerate growth of approved product portfolio and advancement of research and development pipeline - marketscreener.com
Scienture secures $11 million in non-dilutive debt financing - Investing.com
Scienture Secures $11.0 Million in Non-Dilutive Debt Financing to Accelerate Growth of Approved Product Portfolio and Advancement of R&D Pipeline - The Manila Times
$11M debt funds Scienture's hypertension drug and overdose spray - Stock Titan
Scienture Holdings Secures $11M Debt Financing Via Note Purchase Agreement >SCNX - Moomoo
Scienture Holdings, Inc. Secures $11 Million in Non-Dilutive Debt Financing - marketscreener.com
Scienture Holdings Issues Updated Investor Presentation Disclosure - The Globe and Mail
Scienture receives third patent for liquid losartan product - Investing.com
Scienture receives third patent for liquid losartan product By Investing.com - Investing.com Australia
SCIENTURE Announces Third Patent Grant for ARBLI™ (losartan potassium) Oral Suspension, Strengthening Long-Term Market Exclusivity Through 2041 - The Manila Times
Scienture secures third patent for ARBLI™ oral suspension, extending market exclusivity to 2041. - Pluang
[8-K] Scienture Holdings, Inc. Reports Material Event - Stock Titan
Scienture Holdings, Inc. Enters $11.42 Million Secured Note Agreement with Streeterville Capital, LLC – April 2026 - Minichart
Scienture Holdings, Inc. 2025 Annual Report: Company Overview, Executive Leadership, and Financial Highlights - Minichart
Scienture Holdings Secures $11.4 Million Structured Financing Deal - TipRanks
Scienture Holdings Secures $11.42 Million in Secured Notes Financing From Streeterville Capital - TradingView
Scienture (NASDAQ: SCNX) adds 9% and 5% secured notes with asset pledges - Stock Titan
Deep 2025 loss at Scienture (NASDAQ: SCNX) after $26,346,050 impairments - Stock Titan
MSN Money - MSN
SCNX Technical Analysis | Trend, Signals & Chart Patterns | SCIENTURE HOLDINGS INC (NASDAQ:SCNX) - ChartMill
Scienture granted 180-day extension by Nasdaq to regain compliance - MSN
Scienture Holdings, Inc. announced that it has received $11 million in funding - marketscreener.com
SCIENTURE HOLDINGS, INC. (SCNX) - MSN
Scienture Holdings files to sell 2.1M shares for holders - MSN
Scienture Holdings Share Technical Analysis (SCNX) - Investing.com UK
SCNX Should I Buy - Intellectia AI
Scienture files $200M mixed securities shelf - MSN
Scienture Holdings (SCNX) Stock: What Affects Its Direction | Q4 2025: Profit Exceeds ViewsHigh Attention Stocks - newser.com
Scienture Holdings (SCNX) Stock: Stability Assessment (Spikes) 2026-04-20Support Bounce - Xã Vĩnh Công
SCNX | Scienture Holdings, Inc. Common Insider Trading - Quiver Quantitative
Scienture (SCNX) Receives Nasdaq Extension for Compliance - GuruFocus
Finanzdaten der Scienture Holdings Inc-Aktie (SCNX)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.02%
1.33%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):